These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27514142)

  • 1. [BENEFITS AND RISKS AT IMPLEMENTATION OF PROPHILACTIC VACCINES FOR CERVICAL CANCER].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2016; 55(3):28-33. PubMed ID: 27514142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HPV and cervical cancer].
    J Midwifery Womens Health; 2013; 58(2):245-6. PubMed ID: 23451858
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus.
    Ciesielska U; Nowińska K; Podhorska-Okołów M; Dziegiel P
    Adv Clin Exp Med; 2012; 21(2):235-44. PubMed ID: 23214288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus vaccine: a new chance to prevent cervical cancer.
    Monk BJ; Mahdavi A
    Recent Results Cancer Res; 2007; 174():81-90. PubMed ID: 17302188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M
    Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STD vaccine breakthrough. Cervarix would prevent human papilloma virus which can lead to cervical cancer; FDA approval anticipated.
    Health News; 2005 Oct; 11(10):6-7. PubMed ID: 16250092
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papilloma virus: diagnostic, treatment and preventive issues.
    Christopoulos P; Deligeoroglou E; Papadias K; Creatsas G
    Akush Ginekol (Sofiia); 2008; 47(1):35-8. PubMed ID: 18642576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccines for the treatment of cervical cancer.
    Sin JI
    Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of human-papilloma-virus vaccine in Uganda.
    Makokha T
    Lancet Oncol; 2007 May; 8(5):372-3. PubMed ID: 17514798
    [No Abstract]   [Full Text] [Related]  

  • 13. Human papillomavirus vaccines and prevention of cervical cancer.
    Jansen KU; Shaw AR
    Annu Rev Med; 2004; 55():319-31. PubMed ID: 14746524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccine for cancer cervix prevention: Rationale & recommendations for implementation in India.
    Kaur P; Mehrotra R; Rengaswamy S; Kaur T; Hariprasad R; Mehendale SM; Rajaraman P; Rath GK; Bhatla N; Krishnan S; Nayyar A; Swaminathan S
    Indian J Med Res; 2017 Aug; 146(2):153-157. PubMed ID: 29265015
    [No Abstract]   [Full Text] [Related]  

  • 15. Modern screening in cervical cancer. Perspectives of HPV prophylactic vaccines.
    Vlădăreanu R; Andrei C
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):144-54. PubMed ID: 17595860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
    McIntosh J; Sturpe DA; Khanna N
    J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cervical carcinoma and the vaccination experience with Cervarix].
    Berberova M
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccines for precancer and cancer of the uterine cervix. II. Therapeutic HPV vaccines].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2007; 46(8):31-5. PubMed ID: 18642554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV vaccines to prevent cervical cancer and genital warts: an update.
    Dochez C; Bogers JJ; Verhelst R; Rees H
    Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational 9-valent HPV vaccine could prevent almost 90% of cervical cancers.
    Hum Vaccin Immunother; 2014; 10(11):3105-6. PubMed ID: 25789368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.